| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | RedHill Biopharma Divests Talicia Stake to Apotex Subsidiary for $18M | ||
| Mo | Lilly to Acquire Merida Biosciences for $2.875B | ||
| 28.08. | DualityBio and Genentech to Develop Next-Gen ADCs on Novel Payload Platform | ||
| 28.08. | FDA Approves Gilead's Bixlenvo, Once-Daily Pill for Virologically Suppressed Adults with HIV | ||
| 28.08. | SpyGlass Pharma Opens New Irvine Headquarters | ||
| 28.08. | FDA Approves Pfizer-BioNTech COVID-19 Vaccine | ||
| 28.08. | Evonik Invests $108M in Vancouver GMP Facility | ||
| 27.08. | Genezen to Offer Access to 4basebio Synthetic DNA Platform for Viral Vectors | ||
| 27.08. | Biohaven, SK Biopharmaceuticals Ink Licensing Pact for Next-Gen Epilepsy Candidate | ||
| 27.08. | Neuland, Gland Pharma Partner on Sterile API Manufacturing | ||
| 27.08. | Psilera Names Allyson Gage VP of Clinical Development | ||
| 27.08. | Symbiosis Appoints Jay Chima as VP, Business Development | ||
| 27.08. | Circio, Full Circles Partner on In Vivo Cell Therapy | ||
| 26.08. | Artis BioSolutions Opens Genetic Medicines Center of Excellence in Spain | ||
| 26.08. | Körber Releases PAS-X MES 3.4.2 for Pharma Manufacturing | ||
| 26.08. | Lonza Names Samanta Cimitan Chief Commercial Officer | ||
| 25.08. | Hovione Completes Expansion of Loures, Portugal Tablet Manufacturing Center | ||
| 25.08. | Celltrion Launches 300-mg Strength Omlyclo in Europe | ||
| 25.08. | McKesson to Acquire Precision Medicine Group in $2.25B Deal | ||
| 25.08. | Lundbeck, Eversana Expand AI Commercialization Partnership | ||
| 25.08. | Hanmi Pharm, Genentech Ink $2.3B Obesity Drug Licensing Deal | ||
| 25.08. | Cambrex High Point Site Clears FDA, PMDA, TGA Inspections | ||
| 24.08. | The Emmes Group Names Rama Kondru CEO | ||
| 24.08. | Insmed's Brinsupri Approved in Japan to Treat NCFB, Joining US and Europe | ||
| 24.08. | Novotech Opens Tokyo Office, Strengthening Japan Presence |